These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23268190)

  • 1. Hypothetical dopamine dynamics in mania and psychosis--its pharmacokinetic implications.
    Park SY; Kang UG
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():89-95. PubMed ID: 23268190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What are the optimal pharmacokinetic properties of antipsychotic medications?
    Kang UG
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Jan; 36(1):117-21. PubMed ID: 21896301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How antipsychotics become anti-"psychotic"--from dopamine to salience to psychosis.
    Kapur S
    Trends Pharmacol Sci; 2004 Aug; 25(8):402-6. PubMed ID: 15276708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal extent of dopamine D2 receptor occupancy by antipsychotics for treatment of dopamine supersensitivity psychosis and late-onset psychosis.
    Iyo M; Tadokoro S; Kanahara N; Hashimoto T; Niitsu T; Watanabe H; Hashimoto K
    J Clin Psychopharmacol; 2013 Jun; 33(3):398-404. PubMed ID: 23609386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From dopamine to salience to psychosis--linking biology, pharmacology and phenomenology of psychosis.
    Kapur S; Mizrahi R; Li M
    Schizophr Res; 2005 Nov; 79(1):59-68. PubMed ID: 16005191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a novel high-potency positive modulator of K(v)7 channels.
    Dalby-Brown W; Jessen C; Hougaard C; Jensen ML; Jacobsen TA; Nielsen KS; Erichsen HK; Grunnet M; Ahring PK; Christophersen P; Strøbæk D; Jørgensen S
    Eur J Pharmacol; 2013 Jun; 709(1-3):52-63. PubMed ID: 23562623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical antipsychotics: mechanism of action.
    Seeman P
    Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosis pathways converge via D2high dopamine receptors.
    Seeman P; Schwarz J; Chen JF; Szechtman H; Perreault M; McKnight GS; Roder JC; Quirion R; Boksa P; Srivastava LK; Yanai K; Weinshenker D; Sumiyoshi T
    Synapse; 2006 Sep; 60(4):319-46. PubMed ID: 16786561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Striatal dopaminergic D2 receptor occupancy and clinical efficacy in psychosis exacerbation: a 123I-IBZM study with ziprasidone and haloperidol.
    Corripio I; Catafau AM; Perez V; Puigdemont D; Mena E; Aguilar Y; Carrió I; Alvarez E
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):91-6. PubMed ID: 15610950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Quetiapin in bipolar disorders].
    Sümegi A
    Neuropsychopharmacol Hung; 2008 Dec; 10(5):281-91. PubMed ID: 19419014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salience and dysregulation of the dopaminergic system.
    Lahera G; Freund N; Sáiz-Ruiz J
    Rev Psiquiatr Salud Ment; 2013; 6(1):45-51. PubMed ID: 23084802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical example of recovery from psychosis in the context of the theory of psychosis as a state of aberrant salience].
    Murawiec S
    Psychiatr Pol; 2005; 39(2):315-25. PubMed ID: 15881626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aripiprazole, an atypical antipsychotic, prevents the motor hyperactivity induced by psychotomimetics and psychostimulants in mice.
    Leite JV; Guimarães FS; Moreira FA
    Eur J Pharmacol; 2008 Jan; 578(2-3):222-7. PubMed ID: 18021764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine D2 receptors as treatment targets in schizophrenia.
    Seeman P
    Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):56-73. PubMed ID: 20643630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic agents differ in how fast they come off the dopamine D2 receptors. Implications for atypical antipsychotic action.
    Kapur S; Seeman P
    J Psychiatry Neurosci; 2000 Mar; 25(2):161-6. PubMed ID: 10740989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological profiles in rats of novel antipsychotics with combined dopamine D2/serotonin 5-HT1A activity: comparison with typical and atypical conventional antipsychotics.
    Bardin L; Auclair A; Kleven MS; Prinssen EP; Koek W; Newman-Tancredi A; Depoortère R
    Behav Pharmacol; 2007 Mar; 18(2):103-18. PubMed ID: 17351418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-synaptic dopamine D(3) receptor mediates cocaine-induced structural plasticity in mesencephalic dopaminergic neurons via ERK and Akt pathways.
    Collo G; Bono F; Cavalleri L; Plebani L; Merlo Pich E; Millan MJ; Spano PF; Missale C
    J Neurochem; 2012 Mar; 120(5):765-78. PubMed ID: 22145570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The complexity of the dopaminergic synapses and their modulation by antipsychotics.
    Leuner K; Müller WE
    Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S15-20. PubMed ID: 16508891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dopamine on intracellular sodium: a common pathway for pharmacological mechanism of action in bipolar illness.
    Roberts RJ; Repass R; El-Mallakh RS
    World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):181-7. PubMed ID: 19396728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.